🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

A. Rose Brannon

Memorial Sloan Kettering Cancer Center

ORCID: 0000-0003-4610-0149
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile
6.8Author DataRank

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0467
Top 4%
5.0DataRank
Top 4%401 citations

Moriah H. Nissan, Hongxin Zhang, Ritika Kundra, Subhiksha Nandakumar, Calvin Lu +21 more

Papers

Driven by 24 papers — median percentile 88. Top paper: “Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer”.

Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0467
Top 4%
5.0DataRank
Top 4%401 citations

Moriah H. Nissan, Hongxin Zhang, Ritika Kundra, Subhiksha Nandakumar, Calvin Lu +21 more

Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1283
Top 12%
1.8DataRank
Top 12%68 citations

Michal Sarfaty, Min Yuen Teo, Neha Ratna, Cihan Düzgöl, Samuel A. Funt +18 more

Overall survival with circulating tumor DNA-guided therapy in advanced non-small cell lung cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.9009
N/A
0.998DataRank · unranked
19 citations

Emily S. Lebow, Yonina R. Murciano‐Goroff, Gowtham Jayakumaran, Ronglai Shen, A. Rose Brannon +15 more

Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer

Nature Medicine(2022)10.1038/s41591-022-02047-z
N/A
0.792DataRank · unranked
195 citations

Emily S. Lebow, Randy Yeh, Jeeban Paul Das, Azadeh Namakydoust, Paul K. Paik +67 more

Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS

Nature Communications(2021)10.1038/s41467-021-24109-5
N/A
0.782DataRank · unranked
183 citations

Gowtham Jayakumaran, Monica Diosdado, Juber Patel, Anna Razumova, Yu Hu +64 more

Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival

Nature Medicine(2025)10.1038/s41591-024-03362-3
N/A
0.659DataRank · unranked
80 citations

Maria Perry, Joanne F. Chou, Subhiksha Nandakumar, Daniel M. Muldoon, Amanda Erakky +24 more

Retrospective Evaluation of Somatic Alterations in Cell-Free DNA from Blood in Retinoblastoma

Ophthalmology Science(2021)10.1016/j.xops.2021.100015
N/A
0.529DataRank · unranked
33 citations

Diana Mandelker, Jasmine H. Francis, Ira J. Dunkel, A. Rose Brannon, Ryma Benayed +13 more

Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing

Nature Communications(2023)10.1038/s41467-023-42585-9
N/A
0.510DataRank · unranked
29 citations

Mark D. Ewalt, Gowtham Jayakumaran, Iwona Kiecka, Anita S. Bowman, JinJuan Yao +50 more

Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumors

Acta Neuropathologica Communications(2024)10.1186/s40478-024-01846-4
N/A
0.457DataRank · unranked
20 citations

Alexandra Miller, Bridget M Holle, Justin Jee, Siyang Liu, Dara S. Ross +27 more

Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancer

Cell(2024)10.1016/j.cell.2024.11.010
N/A
0.449DataRank · unranked
19 citations

Maria Perry, Samuel I. Gould, Arielle Elkrief, Anton Safonov, Rohit Thummalapalli +23 more

High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancer

Blood Advances(2023)10.1182/bloodadvances.2023011262
N/A
0.396DataRank · unranked
13 citations

Kamal Menghrajani, Sean M. Devlin, Sebastià Franch‐Expósito, Ryan Ptashkin, Swara Y. Patel +13 more

Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma

UNC Libraries(2020)10.17615/cymd-0835
N/A
0.385DataRank · unranked
12 citations

S. Chen, W. Kimryn Rathmell, Caroline Mitchell, I. Espinosa, Lekisha Edwards +8 more

Cell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignancies

Haematologica(2024)10.3324/haematol.2024.285054
N/A
0.345DataRank · unranked
9 citations

Kseniya Petrova‐Drus, Ryan Ptashkin, Mark D. Ewalt, JinJuan Yao, Ying Liu +43 more

Maximizing the clinical utility and performance of cytology samples for comprehensive genetic profiling

Nature Communications(2025)10.1038/s41467-024-55456-8
N/A
0.269DataRank · unranked
5 citations

Chad Vanderbilt, Soo‐Ryum Yang, Subhiksha Nandakumar, Khédoudja Nafa, Rusmir Feratovic +10 more

Enhanced clinical assessment of hematologic malignancies through routine paired tumor:normal sequencing

medRxiv(2022)10.1101/2022.10.03.22280675
N/A
0.130DataRank · unranked
1 citations

Mark D. Ewalt, Gowtham Jayakumaran, Iwona Kiecka, Anita S. Bowman, JinJuan Yao +50 more

Supplementary Table 4 from Tumor Genetic Analyses of Patients with Metastatic Renal Cell Carcinoma and Extended Benefit from mTOR Inhibitor Therapy

10.1158/1078-0432.22450608
Top 100%
0DataRank
Top 100%0 citations

A. Ari Hakimi, Can G. Pham, A. Rose Brannon, Ying-Bei Chen, Luis F. Cunha +15 more

ClearCode34: A Prognostic Risk Predictor for Localized Clear Cell Renal Cell Carcinoma

UNC Libraries(2020)10.17615/e32h-ct35
N/A
0DataRank · unranked
0 citations

Michael W. Kattan, Pheroze Tamboli, Samira A. Brooks, Joel S. Parker, Toni K. Choueiri +10 more

Meta-analysis of Clear Cell Renal Cell Carcinoma Gene Expression Defines a Variant Subgroup and Identifies Gender Influences on Tumor Biology

UNC Libraries(2020)10.17615/sbfe-g063
N/A
0DataRank · unranked
0 citations

W. Kimryn Rathmell, Kathryn E. Hacker, A. Rose Brannon, Matthew E. Nielsen, Eric Wallen +2 more

Detection of FGFR3 alt in plasma cfDNA in metastatic UC patients receiving Erda therapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e16519
N/A
0DataRank · unranked
0 citations

Min Yuen Teo, Samuel A. Funt, Chung‐Han Lee, David H. Aggen, Neha Ratna +11 more

Enhanced clinical assessment of hematologic malignancies through routine paired tumor:normal sequencing

Research Square(2022)10.21203/rs.3.rs-2094202/v1
N/A
0DataRank · unranked
0 citations

Mark D. Ewalt, Gowtham Jayakumaran, Iwona Kiecka, Anita S. Bowman, JinJuan Yao +50 more

Maximizing the clinical utility and performance of cytology samples for comprehensive genetic profiling – A report on the impact of process optimization through the analysis of 4,871 cytology samples profiled by MSK-IMPACT

Research Square(2024)10.21203/rs.3.rs-4746484/v1
N/A
0DataRank · unranked
0 citations

Chad Vanderbilt, Soo‐Ryum Yang, Subhiksha Nandakumar, Khédoudja Nafa, Rusmir Feratovic +10 more

Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma

European Urology(2025)10.1016/j.eururo.2025.04.008
N/A
0DataRank · unranked
22 citations

Ziyu Chen, Karissa Whiting, Irina Ostrovnaya, Andrew T. Lenis, Timothy N. Clinton +26 more

Clinical utility and tissue concordance of circulating tumor DNA in pancreatic ductal adenocarcinoma

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf139
N/A
0DataRank · unranked
4 citations

Lily V. Saadat, Catherine O’Connor, Joanne F. Chou, Anita S. Bowman, Fei Xu +18 more

E-cadherin immunohistochemical expression in invasive lobular carcinoma of the breast: correlation with morphology and CDH1 somatic alterations

Human Pathology(2020)10.1016/j.humpath.2020.06.002
N/A
0DataRank · unranked
52 citations

Abhinita Mohanty, Satshil Rana, Ahmet Zehir, A. Rose Brannon, Timothy M. D’Alfonso +4 more